Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
The Efficacy and Safety of Oxycodone in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
Affiliated Hospital of Nantong University
64 participants
Dec 3, 2024
INTERVENTIONAL
Conditions
Summary
This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.
Eligibility
Inclusion Criteria4
- selective laparoscopic hysterectomy
- general anesthesia
- ASA classification I - III
- aged 18 - 65 years
Exclusion Criteria6
- allergy to oxycodone or any other drugs will be used in the study
- preoperative opioids medication
- opioids abuse
- hepatic or renal dysfunction
- cardiovascular or pulmonary dysfunction
- lack of full civil capacity or refuse to participate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive sulfentanil for PCIA.
Patients will receive oxycodone for PCIA.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06690307